Advertisement · 728 × 90
#
Hashtag
#AMJRespiratory
Advertisement · 728 × 90
Preview
Sleep Apnea Hypoxic Burden Signals Postop Risk Higher sleep apnea specific hypoxic burden was linked to increased 30-day mortality and cardiovascular complications after major noncardiothoracic surgery.

📊 Elevated sleep apnea-specific hypoxic burden at diagnosis predicts significantly higher 30-day post-operative mortality and cardiac complications after major non-cardiothoracic surgery.

👉 www.emjreviews.com/en-us/amj/re...

@amjreviews.bsky.social #AMJRespiratory

1 0 0 0
Preview
Smoking And Quitting Behaviors Vary by Socioeconomic Position Socioeconomic disadvantage was linked to higher smoking, higher addiction, and lower motivation to quit in England.

📖 Editor’s News Pick: Smoking and quitting behaviors vary by socioeconomic position. A new study suggests how to tailor cessation conversations and pathways so support meets patients where they are.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #ATS

0 0 0 0
Preview
Time-of-Day Immunochemotherapy Improves NSCLC Survival Earlier infusions improved PFS and OS in advanced NSCLC in a Phase 3 trial.

⏰🫁🔬 NSCLC Phase 3: first 4 immunochemo cycles before 3pm linked to longer survival, with similar safety and a CD8 activation signal.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #NSCLC #LungCancer

0 0 0 0
Preview
Do GLP-1 Receptor Agonists Raise Chronic Cough Risk? GLP 1 receptor agonists were associated with higher incident chronic cough in adults with type 2 diabetes, with risk persisting even after excluding patients with reflux diagnoses.

😮‍💨🩺 GLP-1s linked to chronic cough.

EHR data (T2D): ~12% higher risk vs other meds. Signal remained after excluding reflux (not causal).

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Pulmonology

4 2 0 0
Preview
Social Factors Shape Lung Cancer in Never-Smokers Chronic lung disease and socioeconomic factors were independently linked to higher lung cancer risk in never-smokers, highlighting the need for multifactorial risk assessment beyond smoking history.

🫁📊 Never-smoker NSCLC: chronic lung disease linked to ~3× higher odds. Living outside the capital city also showed higher odds.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer

0 0 0 0
Preview
Durvalumab Cost-Effectiveness in LS-SCLC Under Review Durvalumab cost-effectiveness in limited-stage small cell lung cancer failed to meet US value thresholds despite longer overall and progression-free survival. Subgroup modeling suggested better value ...

💰🫁 Durvalumab in LS-SCLC improved survival but ICER hit $383k/QALY, above US $150k threshold. Extrathoracic progression subgroup came close.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer

0 0 0 0
Preview
US Inhaler Use Drives Rising Greenhouse Gas Emissions A U.S. analysis found inhalers for asthma and COPD generated nearly 25 million metric tons of CO₂ emissions between 2014 and 2024, with costs exceeding $5 billion.

💨 Inhalers prescribed for asthma and COPD in the U.S. released nearly 25 million metric tons of greenhouse gases over the last decade, 98% from metered-dose inhalers. Could greener options cut emissions?

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #ClimateHealth #Sustainability

2 0 0 0
Preview
Tezepelumab Cuts Oral Steroid Use in Severe Asthma Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg or less and half discontinuing steroids while maintaining control.

💉 Tezepelumab treatment enabled many patients to reduce or stop oral steroids without loss of asthma control in a global Phase IIIb study.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Asthma #LungHealth

0 0 0 0
Preview
New Clues to Protecting Lungs in Sepsis Lung Injury Mouse and human data suggest endothelial ALOX15 and its lipids may help turn some lung clots into protection in sepsis lung injury, highlighting future therapeutic opportunities.

🫁🧬 Preclinical signal: can lung clots protect? Moderate thrombosis in sepsis ARDS limited endothelial injury via ALOX15-driven lipids.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Sepsis #ARDS

5 2 0 0
Preview
Intranasal Vaccine Boosts Protection Against Bird Flu Phase I trial finds an intranasal H5N1 vaccine safely primes mucosal and systemic immunity and enables broad cross clade responses after booster dosing, supporting future influenza pandemic preparedne...

🦠💉 Intranasal vaccine shows early promise against bird flu, priming strong mucosal and systemic immunity and broadening responses across diverse H5N1 clades after an IM booster dose.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #InfectiousDiseases

2 0 0 0
Preview
Lung Cancer Survival Improves, but Funding Threats Loom Lung cancer survival rates are rising across the U.S. thanks to early detection and new treatments, but funding cuts could jeopardize these life-saving advancements.

💨 New data show lung cancer survival has risen to nearly 30%, driven by screening and precision medicine. Yet experts caution that funding cuts could slow advances in prevention, diagnosis, and equitable access to care.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory

1 0 0 0
Preview
Inspiratory Muscle Training May Boost Post-COVID Exercise Tolerance Systematic review suggests inspiratory muscle training improves exercise tolerance and respiratory parameters in post-COVID-19 syndrome, though protocols vary and larger standardized trials are needed...

💨 Inspiratory muscle training appears to enhance exercise tolerance in adults with post-COVID-19 syndrome. Trials show gains in inspiratory strength, diaphragmatic thickness, and six-minute walk distance.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #PostCOVID

0 0 0 0
Preview
Why Stubborn Lung Infections Persist Despite Therapy Whole genome sequencing reveals frequent strain acquisition and adaptive evolution of Mycobacterium avium during chronic infection, highlighting virulence and resistance targets for intervention.

🧬 Understanding stubborn lung infection: a new study reveals how M. avium frequently reinfects, evolves and resists therapy in chronic pulmonary disease, highlighting critical challenges for clinicians.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #InfectiousDiseases #PulmonaryDisease #NTM

0 0 0 0
Preview
CHEST 2025: GLP-1 Receptor Agonists Cut Right Heart Failure Risk In pulmonary arterial hypertension, GLP-1 receptor agonists significantly lowered the risk of right heart failure compared with SGLT2 inhibitors, suggesting enhanced cardioprotective potential.

💉 GLP-1 receptor agonists may protect against right heart failure and pulmonary hypertension in people with obesity, showing promising cardiovascular benefits that extend beyond weight loss, new research reveals.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Cardiology #GLP1 #Obesity

0 0 0 0
Preview
Nasal Irrigation Rivals Sputum Testing in Cystic Fibrosis Nasal irrigation could serve as a reliable, less invasive alternative to sputum tests for detecting airway infections in cystic fibrosis, according to new diagnostic accuracy data.

🧫 Nasal irrigation could replace sputum testing for infection monitoring in cystic fibrosis. The method accurately detects P. aeruginosa and S. aureus, offering a practical, non-invasive diagnostic tool.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #CysticFibrosis

0 0 0 0
Preview
Osimertinib Plus Chemo Extends Survival in EGFR-Mutated NSCLC In EGFR-mutated advanced NSCLC, first line osimertinib plus platinum-pemetrexed prolonged overall survival versus monotherapy, with higher grade 3 or greater adverse events reported.

New front-line strategy: Combining osimertinib with chemotherapy in EGFR-mutated advanced NSCLC achieved a median overall survival of 47.5 months versus 37.6 months with osimertinib alone, a 23% reduced risk of death.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer

0 0 0 0
Preview
Azelastine Nasal Spray Shows Preventive Benefit In a phase 2 randomized trial, azelastine nasal spray reduced PCR-confirmed SARS-CoV-2 infections versus placebo, with similar safety and fewer symptomatic infections observed during the 56-day preven...

🧪 Early data from a Phase II trial found that azelastine nasal spray reduced PCR-confirmed COVID-19 infections, signalling its potential role in respiratory virus prevention alongside vaccines.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #InfectiousDiseases @amjreviews.bsky.social

0 0 0 0
Preview
Distinguishing Mycoplasma pneumoniae in Community-Acquired Pneumonia Hospitalized adults with Mycoplasma pneumoniae CAP were younger with prolonged symptoms, highlighting the need for targeted testing and early empirical treatment strategies.

🧪 Hidden culprit in younger CAP cases: Mycoplasma pneumoniae. Study finds it represents 33% of pneumonia in adults under 50 and is linked to delayed recognition and prior antibiotic use, highlighting diagnostic gaps.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #InfectiousDiseases #AMJ

0 0 0 0
Preview
Food Additives May Disrupt Immune Balance in Asthmatic Children New metabolomic research suggests certain food additives may disrupt immune metabolism, aggravating inflammation and asthma in children through altered T-cell and antigen-presenting cell function.

🍭 Emerging research suggests that certain food additives could disrupt immune pathways and worsen inflammation in children with asthma, offering new clues into dietary impacts on respiratory health.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Asthma #Allergy #PediatricHealth

1 0 0 0
Preview
Indoor Wood Burning in Affluent Areas Problematic for Lung Health Indoor wood burning is linked to declining lung function, with UK data showing rising emissions, increased use among older adults, and concerning health risks for vulnerable populations.

🌫️ Indoor wood burning linked to lung risks. A major UK study finds affluent households using wood burners drive PM2.5 emissions, raising concerns over respiratory health and environmental justice.

Full story:
www.emjreviews.com/respiratory/...

#AMJRespiratory #LungHealth #AirPollution

1 0 1 0
Preview
Machine Learning Improves Prediction of Urgent Care in Lung Cancer Machine learning models using patient-reported outcomes, wearables, and clinical data accurately predicted urgent care visits in lung cancer patients receiving systemic therapy, offering potential for...

🩺 AI models forecast urgent care needs in NSCLC during systemic therapy. Adding wearable and patient-reported data boosts accuracy, enabling proactive interventions to improve care delivery.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer #MachineLearning

2 0 0 0
Preview
Eosinophilic COPD Responds Best to Biologics Biologics targeting type 2 inflammation show strong efficacy in eosinophilic COPD, while non-type 2 approaches remain inconsistent, highlighting the need for biomarker-driven strategies.

🧬 New analysis finds biologics directed at type 2 inflammation deliver the clearest benefit in eosinophilic COPD. Dupilumab stood out for reducing flares and boosting lung function outcomes.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #COPD #Biologics

0 0 0 0
Preview
WCLC 2025: IFITM3 May Improve Immunotherapy Outcomes in SCLC New research identifies IFITM3 as a driver of immunotherapy response in small cell lung cancer, improving MHC-I expression and CD8⁺ T cell activity, with potential as biomarker and target.

🌍 At #WCLC2025, researchers revealed IFITM3 as a key driver of immunotherapy response in SCLC, boosting antigen presentation and T cell activity while emerging as a potential biomarker and target.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer #Immunotherapy #WCLC

1 0 0 0
Preview
WCLC 2025: DLL3 Therapy Shows Promise in Relapsed SCLC A Phase 1 trial of the DLL3-targeted antibody-drug conjugate SHR-4849 shows high response rates and manageable safety in relapsed small cell lung cancer, supporting further clinical development.

🧬 First-in-human trial of DLL3-targeted therapy SHR-4849 demonstrates a 59.5% ORR and 90.5% disease control rate in relapsed small cell lung cancer, with encouraging safety.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #LungCancer

0 0 0 0
Preview
Corticosteroid Use in Asthmatic Children Raises Fracture Risk Nationwide cohort study shows children with asthma face increased fracture risk, especially with recent inhaled or systemic corticosteroid use, highlighting the need for bone health in asthma care.

🫁 Children with asthma face increased fracture risk, linked to corticosteroid use. Recent inhaled exposure posed the highest danger, highlighting the need for bone health in pediatric asthma management.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #Asthma

0 0 0 0
Preview
Latest Insights on GLP-1 Therapy for Sleep Apnea Glucagon-like peptide-1 receptor agonists show promise for reducing apnea-hypopnea index and body weight in patients with obstructive sleep apnea, offering new treatment options beyond PAP therapy.

🫁💊 GLP1 therapy cuts AHI and weight in OSA...

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #SleepApnea #OSA #GLP1

0 0 0 0
Preview
Legionnaires’ Pneumonia Prognosis Better in ICU Severe Legionnaires’ disease in ICU patients showed improved survival, with age and high SOFA scores linked to mortality. Early management and combined antibiotics may enhance outcomes.

🫁 Severe Legionnaires’ disease in ICU patients had more favorable outcomes than past reports suggest. Age and early organ failure scores were key mortality predictors.

www.emjreviews.com/en-us/amj/re...

#InfectiousDiseases #Pulmonology #CriticalCare #AMJRespiratory

1 0 0 0
Preview
Elexacaftor-Tezacaftor-Ivacaftor Cuts Liver Complications in Cystic Fibrosis Elexacaftor–tezacaftor–ivacaftor was linked to a 72% lower risk of severe liver complications in cystic fibrosis patients, with reduced mortality and lung transplantation needs and no increased liver ...

🫁💊 Elexacaftor-tezacaftor-ivacaftor linked to a 72% drop in severe liver complications in cystic fibrosis, plus reduced mortality and lung transplant needs, without higher liver failure risk.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory #CysticFibrosis #LiverDisease

0 0 0 0
Preview
Repurposed Parkinson’s Drug Benztropine Targets Tuberculosis Benztropine, a Parkinson’s disease drug, shows histamine receptor 1-dependent host-directed activity against Mycobacterium tuberculosis, reducing lung bacterial load in preclinical models by up to 70%...

🧠💊 Parkinson’s drug benztropine demonstrates strong host-directed effects against Mycobacterium tuberculosis, reducing lung bacterial load by as much as 70% in preclinical models. Researchers also identified histamine receptor 1 as the key target.

www.emjreviews.com/en-us/amj/re...

#AMJRespiratory

0 0 0 0
Preview
Oxygen Delivery Method Impacts Intubation Risk in ICU Patients High-flow nasal cannula therapy reduced intubation rates in critically ill Pneumocystis pneumonia patients, though survival benefits were not observed, in a multicenter retrospective analysis.

💨 Oxygen delivery choice matters! A new study finds some methods can lower intubation risk in severe pneumonia, though survival rates remain unchanged. Evidence to guide ICU care decisions.

🔗 www.emjreviews.com/en-us/amj/re...

#CriticalCare #Respiratory #Pneumonia #ICU #AMJRespiratory

0 0 0 0